Phoenix Children’s Earns National Designation for Pediatric Pulmonary Hypertension Care
-
April 9, 2026
-
2 min
Clinical Report: Phoenix Children’s Earns National Designation for Pediatric Pulmonary Hypertension Care
Overview
Phoenix Children’s has been designated a PPHNet Network Site, one of only 14 pediatric centers in North America recognized for excellence in pediatric pulmonary hypertension care. This designation enhances access to advanced therapies and collaborative research for patients with complex pulmonary hypertension diagnoses.
Background
Pediatric pulmonary hypertension (PH) is a serious condition that requires specialized care and management. The designation of Phoenix Children’s as a PPHNet Network Site underscores the importance of multidisciplinary approaches in treating this complex disease. Access to advanced therapies and evidence-based protocols is crucial for improving patient outcomes in pediatric populations.
Data Highlights
No specific numerical data provided in the article.
Key Findings
- Phoenix Children’s is one of only 14 pediatric centers in the US and Canada designated as a PPHNet Network Site.
- The designation reflects a commitment to excellence in pediatric pulmonary hypertension care.
- Patients will benefit from access to collaborative research and advanced therapies.
- The multidisciplinary approach integrates various specialties including Pulmonary Hypertension, Cardiology, and Pediatric Surgery.
- This achievement aligns with rigorous standards for patient volume and specialized expertise set by PPHNet.
Clinical Implications
Healthcare professionals can refer patients to Phoenix Children’s for specialized care in pediatric pulmonary hypertension, ensuring access to advanced treatment options. The multidisciplinary approach may enhance patient outcomes and streamline care pathways for complex cases.
Conclusion
The designation of Phoenix Children’s as a PPHNet Network Site represents a significant advancement in pediatric pulmonary hypertension care, highlighting the importance of specialized, collaborative treatment strategies.
Related Resources & Content
- Phoenix Children’s, Phoenix Children's Hospital, 2023 -- Phoenix Children’s Earns National Recognition as a Pediatric Pulmonary Hypertension Network Site
- phoenix children's medical connection — Phoenix Children’s Designated a GLUT1 Deficiency Collaborative Care Network Site
- atlantic health system — Advancing Pediatric Pulmonology at Atlantic Health: A New Level of Clarity for Complex Respiratory Cases
- phoenix children's medical connection — First and only center in Arizona to receive highest designation for advanced life support
- Pediatric Cardiology — Assessment of Pediatric Functional Status Changes During Treatment and Associated Morbidity and Mortality in Children with Pulmonary Hypertension
- Embracing the challenges of neonatal and paediatric pulmonary hypertension - PMC
- https://www.jnjmedicalconnect.com/media/attestation/congresses/pulmonary-hypertension/2025/aepc/macitentan-in-pediatric-pulmonary-arterial-hypertension-results-from-the-phase-3-randomized-controll.pdf
- Phoenix Children’s Earns National Recognition as a Pediatric Pulmonary Hypertension Network Site | Phoenix Children's Hospital
Based on findings from:
Phoenix Children’s Earns National Designation for Pediatric Pulmonary Hypertension Care
Phoenix Children's Medical Connection, 2026.
https://www.phoenixchildrensmedconnection.org/news/phoenix-children-s-earns-national-designation-for-pediatric-pulmonary-hypertension-care
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.